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Abstract
Conjunctiva-associated lymphoid tissue (CALT) is closely associated with ocular surface immunity. This study investigated
the effects of antiglaucoma prostaglandin analogs with or without benzalkonium chloride (BAK) preservative on organized
CALT using an acute toxic model. A total of 48 albino rabbits were used and seven groups of treatments were constituted.
Solutions (50 ml) of PBS, 0.02%BAK,
0.02%BAK+latanoprost,
0.015%BAK+travoprost,
0.005%BAK+bimatoprost,
BAK-freetravoprost
preserved with the SofZiaH system or
BAK-freetafluprost were instilled 15 times at 5-min intervals in both eyes. CALT changes
were analyzed using in vivo confocal microscopy (IVCM), immunohistology in cryosections for detecting MUC-5AC+
mucocytes and CD45+ hematopoietic cells. Antiglaucoma eye drops stimulated inflammatory cell infiltration in the CALT,
and seemed to be primarily related to the concentration of their BAK content. The CALT reaction after instillation of BAK-
containing eye drops was characterized by inflammatory cell infiltration in the dome and intrafollicular layers and by cell
circulation inside the lymph vessels. CD45 was strongly expressed in the CALT after instillation of all BAK-containing
solutions at 4 h and decreased at 24 h. The number of MUC-5AC+ mucocytes around the CALT structure decreased
dramatically after instillation of BAK-containing solutions. This study showed for the first time the in vivo aspect of rabbit
CALT after toxic stimuli, confirming the concentration-dependent toxic effects of BAK. IVCM-CALT analysis could be a
pertinent tool in the future for understanding the immunotoxicologic challenges in the ocular surface and would provide
useful criteria for evaluating newly developed eye drops.
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Introduction
Benzalkonium chloride (BAK), the most widely used preserva-
tive in eye drops, has largely been shown to damage the ocular
surface of patients treated over the long term. These toxic effects
are well documented in the ophthalmological and biomedical
literature, and encompass a large variety of mechanisms involving
the immune system, conjunctival and corneal epithelia, tear film
and most likely corneal nerve sensitivity [1,2,3,4,5]. In other
systems, BAK has already been shown to stimulate and influence
local immune regulation. Exposure of mice ears to BAK induced
significant B cell activation in the draining lymph nodes (DLN),
with an increase in the percentage of B220+ cells [6]. BAK also
influences antigen-presenting cells, as BAK was shown in
experimental irritant contact dermatitis to induce a state of
metabolic activation in a high proportion of epidermal CD1+
Langerhans cells [7].
However, few data are still available concerning BAK and
ocular immunology. We have found that long-term use of topical
treatments containing BAK stimulated both the Th1 and Th2
systems, based on the overexpression of immune-related chemo-
kine receptors by the conjunctival epithelium [2]. Indeed, ocular
surface immunology relies on eye-associated lymphoid tissue
(EALT), which includes conjunctiva-associated lymphoid tissue
(CALT) and lachrymal drainage-associated lymphoid tissue
(LDALT). These systems regulate and concentrate the resident
mucosal immune system and are implicated in ocular innate and
acquired immunity by detecting antigens and distributing
cytokines throughout the ocular surface [8,9]. CALT is involved
in ocular immunology during a large range of physiological and
pathological behaviors, such as antimicrobial defense, allergy,
allograft rejection or immune tolerance [8–10,11]. In models of
ocular pathologies, CALT-like lymphoid aggregates were shown to
develop actively during corneal transplantation in rats [12]. In
mice, CALT follicles were stimulated in the nictitating membrane,
with B/T cells, dendritic cells and macrophages under topical
bacterium (Chlamydia trachomatis) or bacterium-related protein
(cholera toxin) challenges [13].
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rabbit CALT, after lipopolysaccharide (LPS) or tumor necrosis
factor-alpha (TNF) inflammatory stimuli using in vivo confocal
microscopy (IVCM) and immunohistological assessments [14]. An
induction of inflammatory cell infiltration in the dome and in the
intrafollicular layers of CALT and an increase of cell circulation
inside the lymph node vessels were observed. The present study
aimed to explore another type of stimulation on this CALT
structure, namely of toxic origin such as that induced by the well-
recognized contact irritant BAK, and to compare it with the effects
of various BAK-containing antiglaucomatous eyedrops. We
mainly focused on the main prostaglandin analogs (PGA) currently
available worldwide, as belonging to the major family of
antiglaucomatous drugs and as they present different biochemical
properties and irritant features [15,16]. Interestingly, these
eyedrops differ from one another in their BAK concentration
and may provide interesting comparative information on CALT
involvement. Until now the influence of BAK on CALT has not
been reported. CALT activation could therefore become an
important tool for investigating the immunotoxicological impact of
BAK and other preservatives more thoroughly and achieving
further refinements in the determination of the toxicological
profile of newly developed drugs.
Methods
Animals
All experiments were conducted in accordance with the ARVO
Statement for the Use of Animals in Ophthalmic and Vision
Research. Male albino rabbits aged 2.5 months, weighing 2 kg
(New Zealand), were used. A mixture of ketamine (35 mg/kg,
Imalge `ne 500; Merial, Lyon, France) and xylazine (5 mg/kg;
Bayer, Puteaux, France) was used to anesthetize the animals by
intramuscular injections. We chose rabbit model, because it is the
reference animal for standard ocular toxicity testing, and it offers a
large area of conjunctiva for observing the CALT structure
correctly. Before all experiments, ocular surface integrity was
examined using slit-lamp microscopy, and the basal CALT aspect
was examined using IVCM. A total of 48 rabbits were used for this
toxicological model on antiglaucoma prostaglandin analogs. Two
additional normal rabbits were also used for exploring the aspects
of the meibomian glands, goblet cells and CALT structures in
normal unstimulated rabbits. Four rabbits were used to find the
maximal reaction times. The number of rabbits used for each
experiment is shown in Table 1.
Normal rabbit whole-mount conjunctiva, impression
cytology and cryosections for meibomian gland, goblet
cells and CALT structures
In order to better understand the correlations of IVCM images
with standard immunohistology, impression cytology (IC) and
cryosections were used for exploring normal rabbit meibomian
glands, goblet cells and CALT structures.
IC specimens were collected following techniques previously
described in normal rabbits in order to observe the goblet cells
[17]. Two nitrocellulose membranes (Millipore, Bedford, MA,
USA) were applied onto the superior bulbar conjunctiva and then
dipped into tubes containing 1.5 ml of cold PBS with 4%
paraformaldehyde (PFA) for immunohistology. IC specimens were
first incubated with antibodies directed against soluble mucins of
the MUC-5AC gene (kindly provided by Jacques Bara, INSERM,
University Paris 6, Paris, France) for 1 h at 4uC. Sections were
then stained with Alexa FluorH 488 anti-mouse immunoglobulin
(1:500, Molecular Probes, Eugene, OR, USA). Propidium iodide
(PI) was used to stain nuclei red. A confocal microscope
(PCM2000; Nikon, Tokyo, Japan) was used to analyze goblet
cells on impression cytology.
Two normal rabbits were then sacrificed using an overdose
injection of pentobarbital (CEVA Sante ´ Animale, Libourne,
France) for preparing the cryosections in order to observe the
meibomian glands and CALT structures. The whole-mount
conjunctiva with partial eyelids of one of the normal rabbits was
dissected and confocal microscopy was used to observe the
meibomian glands and conjunctival tissue of an entirely dissected
conjunctiva. For the preparation of cryosections, enucleated eyes
of the other normal rabbit were fixed in 4% PFA for 4 h at 4uC,
and 10 mm cryosections were prepared and incubated with
antibodies directed against MUC-5AC products for 1 h at 4uC.
Sections were then stained with the secondary antibody and later
with PI. Images were digitized with a fluorescence microscope
(BX-UCB; Olympus, Melville, NY, USA): particular attention was
paid to the distribution of goblet cells around the CALT structure.
Antiglaucoma eyedrop treatments
Concerning drug testing, eye drops were instilled according to a
previously validated acute toxicological model [17,18]. In order to
follow the dynamic activation of CALT using in vivo confocal
microscopy, four rabbits were anesthetized, two instilled with PBS
and two instilled with 0.02%BAK, soon after the last instillation
(75 min after the first instillation; first instillation was considered as
hour (H) 0) and the CALT changes were observed 75 min, 2 h,
4 h and 24 h after the first instillation.
Seven other groups of three rabbits each (two for 4 h and one
for 24 h, based on the first follow-up study findings) were
constituted according to the different treatments: 50 ml of sterile
PBS, 0.02%BAK or commercial BAK-containing solutions of
0.02%BAK+latanoprost (XalatanH; Pfizer, New York, NY, USA),
0.0015%BAK+travoprost (TravatanH, Alcon, Fort Worth, TX, USA),
0.005%BAK+bimatoprost (LumiganH, Allergan, Irvine, CA, USA),
and two BAK-free prostaglandin analogs, namely
BAK-freetravo-
prost preserved with the SofZiaH system (Travatan ZH, Alcon) and
BAK-free
taflluprost (TaflotanH, Santen, Oy). Using a micropipette, all
solutions were applied in both eyes at 5-min intervals a total of 15
times. The CALT structures were observed at 4 h and 24 h. After
IVCM analysis, the rabbits were sacrificed for preparing eye
cryosections. As previous experiments showed that changes
observed after repeated eyedrop instillations were mild in intensity
and transient, both eyes received the investigated treatments, in
order to reduce the number of animals used and sacrificed. The
Table 1. Number of rabbits used for each ‘‘treatment’’
condition and for each observation time.
Treatment dose 75 min+2h +4h +24 h 4 h 24 h
Sterile PBS 15 instillations 2 4 2
0.02%BAK 15 instillations 2 4 2
0.02%BAK+latanoprost 15 instillations 4 2
0.015%BAK+travoprost 15 instillations 4 2
0.005%BAK+bimatoprost 15 instillations 4 2
BAK-free travoprost Z 15 instillations 4 2
BAK-free tafluprost 15 instillations 4 2
No treatment Normal rabbits 2
doi:10.1371/journal.pone.0033913.t001
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of Pharmaceutical and Biological Sciences Paris Descartes
University approved the protocol (permit number P2.FBB.072.09).
CALT in vivo confocal microscopy observation
The laser scanning IVCM Heidelberg Retina Tomograph
(HRT) II/Rostock Cornea Module (RCM, Heidelberg Engineer-
ing GmbH, Heidelberg, Germany) was used for CALT structure
investigations [17,19]. No special dye injection or other special
preparation was needed. We observed the lymphoid follicles of the
CALT structure according to the previous study [14]: the superior
rabbit conjunctiva was slightly turned over; then we moved the
IVCM objective delicately over the entire bulbar conjunctiva and
partial fornix. The most superficial layer was manually determined
as ‘0’ mm, and the depth of CALT was checked manually by the x-
y-z position of the optical section. For all eyes, at least three
follicles in different areas were recorded and analyzed by IVCM as
repeated image captures or as video frames. As previously
determined [12], the deepest layer of IVCM visualization was
approximately 60–80 mm. To standardize the IVCM analysis of
CALT, the layer from 0 to 15 mm was defined as the ‘dome layers’
of CALT and the layers from 15 to 30 mm as the ‘intrafollicular
layers’. For video recording, the ‘x–y’ axis (z: 0 mm) and the ‘x–z’
axes of the CALT follicles were recorded separately. The
infiltrating inflammatory cells were counted using the Cell CountH
program. The final counts of inflammatory cells (lymphocytes,
polymorphonuclear cells and dendritiform cells) were the averages
of the three follicles of four rabbit eyes.
CALT immunohistology in cryosections and positive cell
counts
At 4 h, the rabbits were euthanized with an overdose injection
of pentobarbital. After enucleation, eyes were fixed in 4% PFA for
4 h at 4uC and 10-mm cryosections were prepared and incubated
with antibodies directed against rabbit CD45 (1:50; CBL1412,
Cymbus Biotechnology, Chandlers Ford, UK) for 2 h at 4uC.
Sections were then incubated with the secondary antibody (Alexa
FluorH488 anti-mouse immunoglobulin, 1:500) for 1 h. PI was
used to stain the nuclei. Images were digitized using an Olympus
BX-UCB fluorescent microscope (Olympus, Melville, NY, USA).
Immunopositive cells were counted on cryosections from three
rabbits per treatment using a 1006100-mm reticle. The center
parts of the CALT follicles were counted and three sections were
used for each treatment. The results were presented as means and
standard deviations for each treatment.
Statistical analysis
Results were expressed as means 6 standard error (SE). The
groups for analysis were compared using factorial analysis of
variance (ANOVA) followed by the Fisher method (Statview V;
SAS Institute Inc., Cary, NC, USA).
Results
IVCM observation of Meibomian glands, Goblet cells and
CALT structure
In IVCM, the aspect of rabbit meibomian glands (Fig. 1A) was
similar to that found in the whole-mount conjunctiva (Fig. 1B).
They appeared morphologically as acinar glands, mainly located
at the tarsal conjunctiva, with a darker central hole in each gland
corresponding to the orifice of the gland duct.
The IVCM goblet cell or mucocyte analysis appeared difficult
due to the various aspects found in individual rabbits. In some
normal rabbits, we could clearly visualize the large hyperreflective,
round/oval cells most probably representing soluble mucin-
secreting goblet cells (Fig. 1C, arrows). They always accumulated
Figure 1. The morphological correlation between IVCM analysis (A, C, E) and immunohistology (B, whole-mount conjunctiva; D,
impression cytology; F, cryosections) for observing the microstructure of superior conjunctiva in normal rabbits. Bar: 50 mm. IVCM
observation for meibomian acinar glands (Fig. A, circle) is similar to that of whole-mount conjunctiva with partial eyelids (Fig. B, circle). Goblet cells
presented large hyperreflective, round or oval aspects (arrows in C for IVCM and D for impression cytology). Several white hyperreflective
inflammatory cells were found (triangles). The CALT structure under the IVCM presented a round/oval aspect (Fig. E) with the goblet cells surrounding
them. Immunohistology of MUC-5AC in cryosections confirmed this distribution of goblet cells (F).
doi:10.1371/journal.pone.0033913.g001
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cells among them (rectangles). Using immunohistology in
impression cytology, these cells were characterized as MUC-
5AC-positive goblet cells (Fig. 1D, arrows) disseminated among
the conjunctival epithelium whose nuclei are stained with PI in
red.
The CALT structure presented a round/oval aspect, which is
quite different from other conjunctiva structures (Fig. 1E, arrow).
As Knop et al. mentioned in previous studies, the goblet cells were
located around the follicles and were never found in the dome
layers. MUC-5AC immunohistology in rabbit conjunctiva trans-
versal cryosections confirmed this distribution of goblet cells
surrounding the follicles (Fig. 1F, arrow).
Dynamic observation of CALT activation 75 min, 2 h and
4 h after instillations of 0.02% BAK
Compared to the untreated rabbit at time zero (Fig. 2A and 2B),
after 15 instillations (75 min from the first instillation) of
0.02%BAK, the CALT structure was not yet activated (Fig. 2C
and 2D). At that time, many goblet cells were found around the
CALT follicles (Fig. 2C, circles), which presented white hyperre-
flective aspects. In the deeper layers of follicles, no special
lymphatic vessel activation was found (Fig. 2D).
Two hours after the first instillation, the CALT activated
significantly after the treatment of 0.02%BAK (Fig. 2E and 2F). At
the dome layers, some hyperreflective inflammatory patterns were
observed (Fig. 2E, arrow). At the same time, the goblet cells,
always found around the CALT, lost their white hyperreflective
aspect and darkened, which was quite different from their aspect at
75 min (Fig. 2C). In the intrafollicular layers, the activation of
lymphatic vessels was observed (Fig. 2F). The infiltration of
inflammatory cells was noted, not only inside the intrafollicular
structure, but also in the parafollicle area (arrows). In the
intrafollicular layers, by video mode, we observed the circulation
of white patterns, possibly inflammatory/immune cells, inside the
lymphatic vessels at a high speed. Figure 2F showed one image of
the video. The infiltrated inflammatory cells were quite different
from standard hyperreflective gray patterns (assumed to be resting
lymphocytes) initially contained in normal CALT (Fig. 2B and 2D,
rectangle), as they presented larger and brighter aspects. Since
IVCM functions with the contrast between the structures, the
original gray patterns were not easy to distinguish at this time due
to the strong contrast of infiltrated inflammatory cells, and we
could not determine whether such cells were still in the CALT
follicles, had migrated or had morphologically changed after
activation.
Four hours after the first instillation, the activation of CALT
and the infiltration of inflammatory cells were more obvious,
reaching maximal levels (Fig. 2G). At the dome of the superficial
layer (Fig. 1G), numerous inflammatory cells were observed
outside (1138.2678.5 cells/mm
2) and also inside the follicle
(56.866.9 cells/mm
2). Hyperreflective and hyporeflective aspects
of goblet cells were no longer observed at this time. Numerous
inflammatory cells could also be noted in the intrafollicular layers
(Fig. 2H). They circulated inside lymphatic vessels, which were
clearly recorded, and more inflammatory cells were found in the
parafollicle areas. This CALT activation decreased at 24 h.
The same dynamics were also observed following the PBS
instillations: no special changes were found in the dome and in the
intrafollicular layers at 75 min, 2 h and 4 h with the persistence of
normal hyperreflective goblet cells (data not shown).
Rabbit CALT activation after antiglaucoma eye drop
instillations
Figure 3 presents the IVCM images of the dome layers of
CALT follicles after 15 instillations with the different eye drops at
4 h (Fig. 3A, C, E, G, I, K, M) and 24 h (Fig. 3. B, D, F, H, J, L,
N). At 4 h, PBS instillations did not induce any obvious changes in
CALT structure (Fig. 3A with 12.863.3 cells/mm
2, P,0.0001
compared to all other groups, Fig. 3O for cell count), while
0.02%BAK (Fig. 3C with 1063.2694.9 cells/mm
2) and
0.02%BAK+-
latanoprost solution (Fig. 3E with 1021.2652.7 cells/mm
2)
(P,0.0001 compared to all other groups for 0.02%BAK and
0.02%BAK+latanoprost groups) induced substantial inflammatory
cell infiltration. IVCM made it possible to register in vivo the x–y
axis and x–z axis aspects of CALT activation, as shown in video S1
Figure 2. IVCM analysis of rabbit CALT, 75 min (A, B), 2 h (C, D) and 4 h (E, F) after the first instillation of
0.02%BAK+latanoprost in
dome layers (A, C, E: 0–15 mm) and in intrafollicular layers (B, D, F: 15–30 mm). All images: 400 mm6400 mm. Note the disappearance of
goblet cells around the CALT structure with the increase of inflammatory cell infiltration in dome layers and the activation of lymphatic vessels with
the increase of inflammatory cell infiltration in the intrafollicular layers.
doi:10.1371/journal.pone.0033913.g002
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PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e33913Figure 3. IVCM analysis in rabbit CALT dome layers (0–15 mm) after 15 instillations of PBS (A, B), 0.02%BAK (C, D),
0.02%BAK+latanoprost (E, F),
0.015%BAK+travoprost (G, H),
0.005%BAK+bimatoprost (I–J),
BAK-freetravoprost (K, L) or
BAK-freetafluprost
(M, N) at 4 h (A, C, E, G, I, K, M) and at 24 h (B, D, F, H, J, L, N). Note the hyperreflective patterns of inflammatory cells, especially after the
application of 0.02BAK%,
0.02%BAK+latanoprost and
0.015%BAK+travoprost (IVCM images: bar, 100 mm). The inflammatory cells were counted using Cell
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0.02%BAK+latanoprost.
Application of
0.015%BAK+travoprost also induced numerous
hyperreflective inflammatory cells around CALT follicles at 4 h
(Fig. 3G; 724.5630.3 cells/mm
2)( P,0.0001 compared to all other
groups).
0.005%BAK+Bimatoprost induced less inflammatory cell
infiltration at 4 h (Fig. 3I; 169.3620.0 cells/mm
2, x–y axis in
video S3 and x–z axis in video S4) (P,0.001 compared to PBS and
BAK-freetravoprost and
BAK-freetafluprost groups at H4). When
BAK-
freetravoprost or
BAK-freetafluprost was instilled onto the rabbit
ocular surface, no particular changes in CALT were found when
compared with PBS treatment (less than 20 cells/mm
2). Twenty-
four hours after eye drop applications, the inflammatory cell
infiltration levels decreased in all groups (Fig. 3. B, D, F, H, J, L
and Fig. 3O for cell counts). However, the inflammatory
infiltrations persisted especially after the instillations of
0.02%BAK,
0.02%BAK+latanoprost,
0.015%BAK+travoprost at mod-
erate levels with 648.5658.45 cells/mm
2, 667.67644.47 cells/
mm
2, 388.33618.15 cells/mm
2 respectively. At this time, there
was no difference between the PBS,
0.005%BAK+bimatoprost,
BAK-
freetravoprost and
BAK-freetafluprost groups, with fewer than 25
cells/mm
2.
Immunohistology analyses of CD45-positive cells in
cryosections
At 4 h, a faint expression of CD45 was observed in the
cryosections (Fig. 4) after the instillation of sterile PBS (100658
cells/mm
2, Fig. 4A). In the same time, we observed the strongest
expression of CD45+ lymphocyte-resembling cells after the
instillations of 0.02%BAK (59676800 cells/mm
2, Fig. 4B),
0.02%BAK+latanoprost (48676993 cells/mm
2, Fig. 4C) and
0.015%BAK+travoprost (54006458 cells/mm
2, Fig. 4D) (P,0.0001
compared to PBS, P,0.001 compared to
0.005%BAK+bimatoprost,
and P,0.0002 compared to
BAK-freetravoprost Z and
BAK-freetafluprost for the three groups, Fig. 4H). These CD45+
cells accumulated in the dome and intrafollicular layers of the
CALT follicles and were also scattered in the conjunctival stroma
adjacent to CALT follicles.
0.005%BAK+bimatoprost (Fig. 4E),
BAK-freetravoprost (Fig. 4F) and
BAK-freetafluprost (Fig. 4G) caused
only faint infiltration of CD45+ cells (11676491 cells/mm
2 and
8006361 cells/mm
2, respectively, with no significant differences
with PBS, Fig. 4H).
Immunohistological analyses of MUC-5AC+ mucocytes
After the instillation of PBS, MUC-5AC+ mucocytes persisted,
as in normal rabbits, located around the follicles (Fig. 5A), even
between two neighboring CALTs. No goblet cells were observed
in the dome layers. After the instillations of all BAK-containing
solutions, mucocytes around the CALT dramatically decreased
with unstructured green patterns (Fig. 5B and 5C). However, after
the instillation of either BAK-free solution, MUC-5AC-positive
cells were normally found around the CALT follicles (Fig. 5D for
BAK-freetravoprost and Fig. 5E for
BAK-freetafluprost), even though
they were larger than the control ones.
Discussion
This study investigated the in vivo aspects of CALT after topical
antiglaucoma treatments with prostaglandin analog containing
different concentrations of BAK. BAK is a quaternary ammonium
commonly used in eye drops where it prevents microbial
contamination and is also widely found in the environment. It is
a well-recognized irritant that also has sensitizing properties and
could even be, albeit rarely, a contact allergen [20]. Many studies
have reported its toxic effects to ocular surface epithelia, causing
ocular surface epithelia disruption and apoptosis, stimulating
inflammatory reactions, impairing corneal nerves, destroying
goblet cells and even enhancing fibrosis in the subconjunctival
spaces [5]. Considering these adverse effects most particularly
observed in long-term topical treatments such as in glaucoma
therapy, BAK-free formulations were developed to be safer for the
ocular surface. Recently, we have conducted toxicological studies
on two new BAK-free formulations of prostaglandins, one
containing a SofZia ionic buffer named travoprost Z and the
other, called tafluprost, which is fully preservative-free. BAK-free
travoprost was shown to improve cell viability and reduced
apoptosis compared with BAK-containing latanoprost or travo-
prost [21], and preservative-free tafluprost has confirmed its good
tolerance both in vitro and in vivo [22–23]. These current
experimental results were in accordance with previous in vitro
and in vivo studies, proving that the damage caused to ocular
surface tissues, especially to cornea and conjunctiva epithelia, was
primarily related to the BAK concentration [24–26].
IVCM has now been widely used by researchers and
ophthalmologists to explore the ocular microstructures. Nowadays,
after having thoroughly explored the corneal tissue in normal and
pathological settings, we succeeded in analyzing conjunctival
epithelium, goblet cells, meibomian glands as well as CALT. The
development of the IVCM made it possible to observe this latter
distinctive immunological structure with no specimen injection or
preparation. We investigated an active CALT in vivo using IVCM
by characterizing the infiltration of inflammatory cells, the absence
or pathological aspects of the surrounding goblet cells and the
activation of lymphatic vessels in the intrafollicular structures.
IVCM was thus not only found to be suitable for morphological
observation, but could also be used for the analysis of the sole part
of the immune system that is directly accessible to observation.
IVCM analysis has been used in glaucomatous patients treated
with chronic BAK-containing eye drops by showing ocular surface
alterations with the reduction of the density of superficial epithelial
cells, the activation of stromal keratocytes, and the reduction in
sub-basal nerves and increase in nerve tortuosity [4]. Confirmed
by an ex vivo study using flat-mount immunofluorescence, Peebo et
al. identified the corneal lymph vessels in a rat neovascularization
model using the same in vivo confocal microscopy: the morphology
of lymph vessels was highly specific and enabled subsequent
monitoring of lymphatic activity, including the dynamics of
leukocyte movement within lymphatics [27].
Several ocular problems such as dry eye, uveitis and scleritis are
closely associated with systemic autoimmune disorders. Contrib-
uting significantly to the study of corneal nerves, IVCM has been
proposed as a noninvasive method for accurately diagnosing and
assessing the progression of diabetic neuropathy [28]. Research
exploring the conjunctiva-associated immune system has great
potential to contribute to a better understanding of ocular surface
immunity, systemic problems as well as new vaccine strategies
[20,29]. This in vivo study has confirmed the presence of CALT in
rabbit eyes and its activation following toxic stimuli using a
noninvasive technique. We followed this dynamic in vivo analysis
Count software attached to the IVCM (O). ¤ P,0.0001 compared to PBS and ¤¤ P,0.03 compared to PBS; * P,0.0001 compared to
0.02%BAK+latanoprost and 0.02%BAK groups; 1 P,0.0001 compared to
0.015%BAK+travoprost group; # P,0.03 compared to
0.005%BAK+bimatoprost
group.
doi:10.1371/journal.pone.0033913.g003
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PLoS ONE | www.plosone.org 6 March 2012 | Volume 7 | Issue 3 | e33913Figure 4. Immunofluorescence staining of CD45 in the cryosections at 4 h: very few CD45+ cells were observed after PBS
applications (A), the strongest expression of CD45+ cells in CALT follicles was found after instillation of 0.02%BAK (B),
0.02%BAK+latanoprost (C) and
0.015%BAK+travoprost (D). Scattered CD45+ cells were also found after the instillation of
0.005%BAK+bimatoprost (E),
BAK-freetravoprost Z (F) or
BAK-freetafluprost (G). (Bar, 100 mm). CD45+ cell counts in cryosections are presented in Figure 4H. * P,0.0001 compared to
PBS, P,0.001 compared to
0.005%BAK+bimatoprost, and P,0.0002 compared to
BAK-freetravoprost Z or
BAK-freetafluprost.
doi:10.1371/journal.pone.0033913.g004
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PLoS ONE | www.plosone.org 7 March 2012 | Volume 7 | Issue 3 | e33913by observing the same animal throughout all the experiments,
before and after the instillations of ophthalmological solutions, thus
avoiding variations between animals. In addition, the information
provided by IVCM, including the topography, size and inflamma-
tory cell infiltration, goblet cell counts inside and outside the CALT
structures, accurately reflects the activation status of the whole
ocular surface and could become important criteria for evaluating
the cytotoxicity of newly developed drug formulations. IVCM
analyses have already been used for testing new formulations, such
as cationic emulsions [30]. They were useful for toxicological
purposes and showed that CALT may be stimulated after toxic
challenge, consistent with the widely demonstrated proinflamma-
tory effects of antiglaucoma drugs and their preservatives [1,3]. In
our toxicological model, the inflammatory cell infiltration in CALT
seemed to be primarily related to the BAK concentration. These
immunoinflammatory changes in CALT, and possibly EALT and
LDALT, may actively participate in the strong inflammatory and
apoptotic reactions observed after applications of these BAK-
containing eye drops [31].
In humans, we highlighted the presence of CALT in patients
suffering from severe allergic reactions in a previous study [14].
This structure could certainly constitute a new ocular surface
entity that could be included in the IVCM-ocular surface scoring
system for future immunological and toxicological experiments as
well as for the exploration of ocular surface disorders in human
pathologies.
Supporting Information
Video S1 X–Y axis in IVCM analysis of CALT structure 4 h
after instillations of
0.02%BAK+latanoprost. The depth of IVCM is
maintained at 0 mm. A live three-dimensional visualization of a
rabbit CALT follicle in vivo shows the inflammatory cell
infiltration, especially around but also inside the follicles.
(AVI)
Video S2 X–Z axis in IVCM analysis of CALT structure 4 h
after instillations of
0.02%BAK+latanoprost. The depth of IVCM
analysis decreases from 0 mmt o3 0mm. A live visualization of a
rabbit CALT follicle shows the appearance of lymphatic vessels.
(AVI)
Video S3 X–Y axis in IVCM analysis of CALT structure 4 h
after instillations of
0.005%BAK+bimatoprost. The depth of IVCM is
maintained at 0 mm. The rabbit CALT follicle shows less
Figure 5. Immunofluorescence staining of MUC-5AC in the cryosections at 4 h: normal goblet cell patterns after PBS applications
(A). The follicle size increased, and no or rare goblet cells were observed after the instillations of 0.02%BAK (B) or
0.02%BAK+latanoprost (C) with
unstructured green paths. BAK-free travoprost Z (D) and BAK-free tafluprost (E) presented almost normal MUC-5AC staining. (Images 6200).
doi:10.1371/journal.pone.0033913.g005
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PLoS ONE | www.plosone.org 8 March 2012 | Volume 7 | Issue 3 | e33913inflammatory cell infiltration when compared to that of
0.02%BAK+latanoprost.
(AVI)
Video S4 X–Z axis in IVCM analysis of CALT structure 4 h
after instillations of
0.015%BAK+bimatoprost. The depth of IVCM
decreases from 0 mmt o3 0mm. The rabbit CALT follicle shows
less activation when compared to that of
0.02%BAK+latanoprost.
(AVI)
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